Group 1: Company Overview - Company Code: 688278, Company Name: Xiamen Te Bao Biological Engineering Co., Ltd. [1] - Event Date: September 18, 2024, from 14:00 to 16:00 [3] - Location: Shanghai Roadshow Center [3] Group 2: Long-acting Growth Hormone Product - The application for the long-acting growth hormone product (Yipeisheng) was accepted by the National Medical Products Administration in January 2024 [3][4] - The product is currently in the technical review stage [3][4] Group 3: Stock Incentive Plan - The company has developed a stock incentive plan to align the interests of shareholders, the company, and core team members [4] - The plan includes performance indicators based on net profit growth rates of no less than 30%, 70%, and 120% for the years 2024-2026, using 2023 net profit as the baseline [4] Group 4: Future Commercialization Plans - The commercialization planning for growth hormone is still in the research phase, with strategies to be developed based on product approval progress and actual conditions [4] Group 5: Investor Communication - The company ensured that the information disclosed during the performance briefing was true, accurate, complete, timely, and fair, with no significant undisclosed information leaks [4]
特宝生物(688278) - 投资者关系活动记录表(2024年半年度制药及生物制品专场集体业绩说明会)